Skip to main content
main-content

Cardiovascular disorders

News

02-05-2018 | Cardiovascular outcomes | News

Low BP may flag cardiac risk in diabetes patients

Analysis of the SAVOR-TIMI trial supports a relationship between low blood pressure and cardiovascular risk in patients with type 2 diabetes.

02-01-2018 | Glycemic control | News

Glucose targets unmet in many patients with type 2 diabetes and hypertension

Less than half of patients with type 2 diabetes and hypertension who are assigned to strict glycated hemoglobin targets reach their goal within 12 months, German study data show.

11-16-2017 | Cardiovascular disorders | News

Coronary artery calcification predicts CVD risk regardless of diabetes status

Results of a multiethnic cohort study suggest that coronary artery calcium scoring can predict long-term cardiovascular risk in patients with and without metabolic abnormalities.

Read more

Related topics

Specific

Opinion

12-14-2017 | Guidelines | Editorial | Article

What is new in the 2018 American Diabetes Association Standards of Medical Care in Diabetes?

Jay Shubrook, Chair of the American Diabetes Association’s Primary Care Advisory Group, outlines what's new in 2018's ADA Standards of Care update. 

11-22-2017 | Cardiovascular disorders | Editorial | Article

Diabetes in special situations: Sodium-glucose co-transporter-2 inhibitors in acute coronary syndrome

Editorial Board member Sanjay Kalra presents a pragmatic approach to the use of sodium-glucose co-transporter-2 inhibitors in patients affected by acute coronary syndromes.

10-23-2017 | Cardiovascular disorders | Editorial | Article

Diabetes in special situations: Glucagon-like peptide-1 receptor agonist use in acute myocardial infarction

Editorial Board member Sanjay Kalra presents a pragmatic approach to the use of glucagon-like peptide-1 receptor agonists in patients affected by acute myocardial infarction.

Journal articles and book chapters

01-25-2018 | Heart failure | Review | Article

Effect of glucose-lowering therapies on heart failure

Nat Rev Cardiol 2018; Advance online publication. doi: 10.1038/nrcardio.2017.211

01-05-2018 | Cardiovascular outcomes | Review | Article

Pharmacological prevention of cardiovascular outcomes in diabetes mellitus: Established and emerging agents

Saxon DR, Rasouli N, Eckel RH. Drugs 2018; 78: 203–214. doi: 10.1007/s40265-017-0857-3

12-29-2017 | Non-alcoholic fatty liver disease | Review | Article

Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus

This review discusses the strong association between nonalcoholic fatty liver disease and the risk of chronic vascular complications in patients with type 1 or type 2 diabetes mellitus.

Nat Rev Endocrinol 2017; 14: 99–114. doi: 10.1038/nrendo.2017.173

Authors:
Giovanni Targher, Amedeo Lonardo, Christopher D. Byrne
image credits